Uniform, national measures should define HIV/AIDS care

August 18, 2010

To improve the quality of HIV care and treatment nationwide, 17 measures such as screening and prevention for infections and monitoring of antiretroviral therapy should be adopted uniformly, according a work group led by a Kaiser Permanente researcher.

The work group's study results appear in the current issue of Clinical .

The study shows how national quality performance measures were developed, approved by national bodies, and are being implemented, said Michael Horberg, MD, MAS, FACP, director of HIV/ for Kaiser Permanente, a research scientist at the Kaiser Permanente Division of Research, and the lead author of the study. Horberg was one of two co-chairs who led the effort and determined the measures to be included and their specifications. Kaiser Permanente is the largest private provider of HIV care in the United States.

The measures assess a wide range of care, including patient retention, screening and prevention for infections, immunization, and initiation and monitoring of antiretroviral therapy. The measures are being pilot tested and have been endorsed by the National Quality Forum, National Committee For Quality Assurance, American Medical Association, the HIV Medical Association, Infectious Disease Society of America, and Health Resources and Service Administration (Health & Human Services). "Taken together, these measures represent the most important aspects of HIV care that impact the greatest number of HIV-infected individuals in the Unites States today," Horberg said.

"HIV disease has become a complex, chronic condition. Measurement of quality of care is an essential component of successful therapy," Horberg added. "And once those measurements are made, it's important that they be used to create quality improvement programs that set and create expectations for a certain level of quality care."

Many of the measures outlined by the work group already are in place at Kaiser Permanente, which is the largest private provider of HIV care in the United States and has a large HIV registry of 17,000+ patients that's enabled Kaiser Permanente to improve its HIV management so that the mortality rate for Kaiser Permanente HIV patients is half the national average.

As noted in the study, the measures do not reflect all aspects of HIV care. Most measures related to pregnancy processes and outcomes are not included. Pediatric measures are similarly not present, although the HRSA's HIV-AIDS Bureau is developing a set of those measures.

Related Stories

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.